In this review, we discuss three main therapeutic concepts and their possible use for perioperative treatment or prevention of early‐stage metastatic disease; these include (i) specific inhibition of Ang2 without inhibition of Ang1, (ii) Ang1 supplementation, and (iii) selective Tie2 activation. The gene discussed is TEK; the disease is metastatic neoplasm.